Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
Argus Health
US Army
Fish and Richardson

Generated: December 16, 2017

DrugPatentWatch Database Preview

CLOZAPINE Drug Profile

« Back to Dashboard

When do Clozapine patents expire, and when can generic versions of Clozapine launch?

Clozapine is a drug marketed by Barr Labs Inc, Mylan Pharms Inc, Teva Pharms Usa, Accord Hlthcare, Aurobindo Pharma Ltd, Ivax Sub Teva Pharms, Mayne Pharma, Mylan, Par Pharm, Sandoz, and Sun Pharm Inds Inc. and is included in twelve NDAs.

The generic ingredient in CLOZAPINE is clozapine. There are thirteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the clozapine profile page.
Drug patent expirations by year for CLOZAPINE

Pharmacology for CLOZAPINE

Medical Subject Heading (MeSH) Categories for CLOZAPINE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
SandozCLOZAPINEclozapineTABLET;ORAL074546-002Aug 30, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
MylanCLOZAPINEclozapineTABLET;ORAL075417-005Apr 15, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncCLOZAPINEclozapineTABLET;ORAL075713-001Nov 15, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Par PharmCLOZAPINEclozapineTABLET;ORAL075162-001Apr 26, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr Labs IncCLOZAPINEclozapineTABLET, ORALLY DISINTEGRATING;ORAL090308-001Nov 25, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsCLOZAPINEclozapineTABLET;ORAL076809-002Dec 16, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
MylanCLOZAPINEclozapineTABLET;ORAL075417-003Apr 15, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Accord HlthcareCLOZAPINEclozapineTABLET;ORAL202873-001Nov 25, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncCLOZAPINEclozapineTABLET;ORAL075713-004Nov 7, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms IncCLOZAPINEclozapineTABLET, ORALLY DISINTEGRATING;ORAL201824-003Sep 15, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: